Sanofi is continuing to splash the cash for autoimmune and immunology assets this spring by penning a new deal with ...

Earendil Labs, an expert in AI-driven research and development of next-generation biologics therapeutics, and Sanofi have ...

Sanofi's Qfitlia gains FDA approval, offering fewer injections in hemophilia care. Check out my recommendation for SNY stock.

Despite 2024 top-line numbers some analysts found disappointing, L’Oréal doubled down on profits, achieving record gross and operating margins. Excluding Aēsop, acquired from Natura&Co. in 2023, its ...

Despite a haemophilia market bustling with rivals, Qfitlia’s broad label and favourable dosing regimen could give it an upper hand.

Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and ...

Merida Biosciences has emerged from Third Rock Ventures with $121 million in first-round financing for a pipeline of drugs ...

Sanofi CEO Paul Hudson was among seven top business officials from different countries who spoke at the meeting, according to state news agency Xinhua (Chinese). The French pharma in December made ...

Mr Radie held leadership roles as President, CEO and Director of Topaz Pharmaceuticals, a specialty pharmaceutical company acquired by Sanofi Pasteur, and Transmolecular, Inc., a biotechnology company ...

Sanofi now covers seven major therapeutic areas: Sanofi’s CEO is Christopher A. Viehbacher, who has been in this position since 1st December 2008. Christopher is also a Sanofi board member and a ...

Speaking to Fortune last year, Sanofi CEO Paul Hudson described how he used the “Fight Club” approach to encourage employees to begin using its AI agent. Hudson initially got a small group of ...

Soleo Health has been named the exclusive in-network specialty pharmacy for Qfitlia (fitusiran) by Sanofi, the first ...